Consider a situation where a high-net-worth investor, accustomed to the comfort of SEBI-regulated mutual funds, questions why their proposed Specialized Investment Fund (SIF) strategy does not offer the same level of granular regulatory disclosure or daily NAV transparency. The investor is essentially comparing the exchange-traded environment, which is governed by centralized clearing corporations, against the private, bilateral world of Over-the-Counter (OTC) transactions.
In the public exchange space, every participant benefits from a regulatory buffer that mitigates systemic risk; if one party defaults, the clearing corporation steps in to ensure market integrity. This uniform protection is a hallmark of the products you typically distribute to retail clients.
When we shift our focus to the OTC market, the paradigm changes significantly. These strategies often involve bespoke contracts that are not traded on a centralized exchange, meaning there is no third-party clearing entity to guarantee the trade. For a distributor, this means the risk is no longer just about the market moving against the investor, but about the counterparty failing to honor their contractual obligations.
In India, while large institutions navigate these private arrangements with sophisticated risk models, a retail investor or an HNI venturing into such complex strategies must understand that the absence of a central regulator increases the reliance on the financial health of the specific counterparty.
This distinction is crucial when conducting a suitability assessment for an SIF strategy. If an investor with a limited appetite for credit or systemic volatility is funneled into a complex derivative-heavy strategy, you face a significant compliance risk. You must clearly explain that in OTC transactions, the safety of the capital is tethered to the creditworthiness of the institutions involved in the trade, rather than the collective guarantee of an exchange.
For the ₹10 lakh minimum investment cohort, it is your responsibility to ensure they recognize that they are trading standardized regulatory oversight for the bespoke flexibility of the strategy. Protecting the client from overexposure to systemic risk begins with this honest, transparent conversation about where their money is actually being managed.
Nuance
Check Your Understanding
An investor in an SIF strategy asks about the primary difference between the exchange-traded derivatives they see on the NSE and the bespoke OTC instruments held in their portfolio. Which of the following is the most accurate response a distributor can provide?
When evaluating an SIF investment strategy that utilizes significant OTC derivative exposure, why is systemic risk a critical factor for the distributor to discuss with a client?
This is a companion read for Section 13.5 — Types of Derivatives Market from Pass Certification Examination for Mutual Fund - Specialized Investment Fund Distributors by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.